PMID: 11604322Oct 18, 2001Paper

Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers

Current Opinion in Biotechnology
S Weiss, T Chakraborty

Abstract

The concept of transkingom transfer of DNA from bacteria to other organisms has recently been extended to include eukaryotic host cells. Intracellular bacteria have been shown to transfer eukaryotic expression plasmids to mammalian host cells in vitro and in vivo. This can be used to induce immune responses towards protein antigens encoded by the plasmid, to complement genetic defects or even to direct the production of proteins in appropriate organs. The ease of generating such vehicles makes this a highly attractive area for further research.

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K Y Leung, B B Finlay
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·W Schaffner
Feb 14, 1998·Nature Medicine·D B Lowrie
Mar 6, 1998·Nature Biotechnology·D E Higgins, D A Portnoy
Sep 22, 1998·Nature Biotechnology·C Grillot-CourvalinP Courvalin
Oct 28, 1999·American Heart Journal·R C Brunham, Dj Zhang
Feb 1, 2000·Molecular Medicine Today·M T ShataD M Hone
Mar 23, 2000·FEMS Immunology and Medical Microbiology·S SprengW Goebel
Mar 23, 2000·FEMS Immunology and Medical Microbiology·A DarjiS Weiss
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R XiangR A Reisfeld
Nov 18, 2000·Antisense & Nucleic Acid Drug Development·G DietrichW Goebel
Dec 7, 2000·Medical and Pediatric Oncology·H N LodeR A Reisfeld

❮ Previous
Next ❯

Citations

Jun 8, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sara Leschner, Siegfried Weiss
Oct 15, 2010·Nature Reviews. Cancer·Neil S Forbes
Apr 9, 2005·Gene Therapy·I CastagliuoloG Palù
Jun 24, 2005·Gene Therapy·A LanerC Grillot-Courvalin
Jan 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Brittany D NeedhamM Stephen Trent
Aug 10, 2011·DNA and Cell Biology·Won Suck YoonYong Keun Park
Sep 24, 2010·Journal of Biomedicine & Biotechnology·Sara Pérez-Luz, Javier Díaz-Nido
Oct 6, 2004·Expert Opinion on Biological Therapy·Lina WangRoss L Coppel
Sep 23, 2009·Expert Opinion on Biological Therapy·Achim Aigner
Apr 20, 2012·Comparative Immunology, Microbiology and Infectious Diseases·Seyed Davoud JazayeriAbdul Rahman Omar
Sep 2, 2008·Current Opinion in Biotechnology·Adam T St JeanNeil S Forbes
Aug 21, 2015·Research in Microbiology·Katsunori SuzukiShinji Yamamoto
Sep 1, 2008·Microbial Biotechnology·Sukhadeo Barbuddhe, Trinad Chakraborty
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·I FajacC Grillot-Courvalin
Oct 7, 2006·Biotechnology Progress·Benjamin E SimonRonald A Barry
May 18, 2016·International Journal of Microbiology·Cheng-Zhi WangAbraham Eisenstark
Apr 19, 2011·Current Opinion in Biotechnology·Robert M Hoffman
Jan 13, 2009·Free Radical Biology & Medicine·Michael A J Zieger, Mahesh P Gupta
Feb 18, 2014·Cell Stem Cell·Hailiang LiuWeizhi Ji
Apr 4, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rebecca J Critchley-ThorneGeorges Vassaux
Feb 24, 2018·Frontiers in Microbiology·M Gabriela KramerRobert M Hoffman
Oct 7, 2004·The Journal of Gene Medicine·Che-Hsin LeeAi-Li Shiau
Aug 14, 2018·Cancer Gene Therapy·Síle A JohnsonDaniel M Wall
Feb 13, 2021·Journal of Fungi·Jonatan Niño-SánchezIoannis Stergiopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.